Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

643 public trials 134 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

NCT02064829

Conditions
Breast Diseases, Breast Neoplasms, Locally Recurrent Breast Cancer, +5 more
Locations
  • Sorrento investigational site Fayetteville, Arkansas, United States
  • Sorrento investigational site Chattanooga, Tennessee, United States
  • Sorrento investigational site Memphis, Tennessee, United States
  • Sorrento investigational site Flower Mound, Texas, United States
View all 20 locations
View Trial Details
Completed

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

NCT00633464

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
Locations
  • Local Institution Graz, Austria
  • Local Institution Vienna, Austria
  • Local Institution Brno, Czechia
  • Local Institution Prague, Czechia
View all 19 locations
View Trial Details
Completed

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

NCT00490646

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Local Institution Caen, France
  • Local Institution Grenoble, France
  • Local Institution Saint-Priest-en-Jarez, France
  • Local Institution Toulouse, France
View all 19 locations
View Trial Details
Completed

A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

NCT00370552

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • East Valley Hematology And Oncology Medical Group Burbank, California, United States
  • Wilshire Oncology Medical Group, Inc. La Verne, California, United States
  • Ucsf-Comprehensive Cancer Center San Francisco, California, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
View all 25 locations
View Trial Details
Completed

Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer

NCT00593827

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Birmingham Hematology & Oncology Associates Llc Birmingham, Alabama, United States
  • Hematology Oncology Associates Phoenix, Arizona, United States
  • Northern Arizona Hematology & Oncology Associates Sedona, Arizona, United States
  • Arizona Oncology Associates D.B.A. Hematology Oncology Tucson, Arizona, United States
View all 57 locations
View Trial Details

Related conditions